EFFECTIVENESS AND SAFETY OF A SECOND-LINE RESCUE THERAPY IN HOSPITALISED PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS STEROID-REFRACTORY AFTER FAILING INFLIXIMAB OR CICLOSPORIN (REASUC STUDY)

María José García  ¹     Sabino Riestra  ²     Aurelien Amiot  ³     Mette Julsgaard  ^{4, 5}     Irene García de la filia Molina  ⁶     Margalida Calafat Sard  ⁷     Mariam Aguas  ⁸     Luisa de la Peña  ⁹     Cristina Roig Ramos  ¹⁰     Berta Caballol Oliva  ¹¹     María José Casanova  ¹²     Klaudia Farkas  ¹³     Trine Boysen  ¹⁴     Luis Bujanda  ¹⁵     Camila Cuarán  ¹⁶     Ecaterina Daniela Dobru  ¹⁷     Fotios Fousekis  ¹⁸     Carla Jerusalén Gargallo-Puyuelo  ¹⁹     Edoardo Vincenzo Savarino  ²⁰     Xavier Calvet  ²¹     Jose Maria Huguet  ²²     Limas Kupcinskas  ²³     Julia López-Cardona  ²⁴     Tim Raine  ²⁵     Joep van Oostrom  ²⁶     Javier Gisbert  ²⁶     María Chaparro  ^26    
1 Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, Spain
² Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
³ CHU Bicêtre, Universite Paris Saclay, Paris, France
⁴ Aarhus University Hospital, Aarhus, Denmark
⁵ PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Aalborg, Denmark
⁶ Hospital Universitario Ramón y Cajal, Madrid, Spain
⁷ Hospital Universitari Germans Trias i Pujol, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain
⁸ La Fe University and Politecnic Hospital, Health Research Institute La Fe, Valencia, Spain
⁹ Bellvitge University Hospital, Barcelona, Spain
¹⁰ Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
¹¹ Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain
¹² Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain
¹³ University of Szeged, Szeged, Hungary
¹⁴ Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
¹⁵ Biodonostia Health Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universidad del País Vasco (UPV/EHU), San Sebastián, Spain
¹⁶ Hospital Universitario Miguel Servet, Zaragoza, Spain
¹⁷ University of Medicine and Pharmacy, Science and Tehnology "G E Palade" Tg.Mures, Târgu-Mureș, Romania
¹⁸ University Hospital of Ioannina, Ioannina, Greece
¹⁹ University Clinic Hospital Lozano Blesa, Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain
²⁰ Azienda Ospedale Università di Padova (AOUP), Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Padua, Italy
²¹ Servei d'Aparell Digestiu, Corporació Sanitària Universitària Parc Taulí, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Universitat Autònoma de Barcelona, Barcelona, Spain
²² General University Hospital of Valencia, Valencia, Spain
²³ Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania
²⁴ Guy's and St Thomas' Hospital, London, United Kingdom
²⁵ Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
²⁶ Universitair Medische Centra (UMC), Amsterdam, Netherlands

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)